Showing results (821-830 of 940) with videos related to

Sort By:
Pageof 94
Circulation Research|February 27, 2020
Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3Shiju Ye, Wu Luo, Zia A Khan, et al.
Nephrology (Carlton, Vic.)|January 9, 2014
Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney diseaseShui-juan Shen, Zuo-xiang Hu, Qing-hua Li, et al.
Acta Pharmacologica Sinica|December 19, 2023
OTUD1 promotes hypertensive kidney fibrosis and injury by deubiquitinating CDK9 in renal epithelial cellsMeng-Yang Wang, Tian-Xiang Yu, Qin-Yan Wang, et al.
International Journal of Ophthalmology|November 20, 2018
Abnormal resting-state functional network centrality in patients with high myopia: evidence from a voxel-wise degree centrality analysisYu-Xiang Hu, Jun-Rong He, Bo Yang, et al.
Journal of Translational Medicine|August 5, 2010
Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditionsWan-Zhang Yang, Yun Zhang, Fang Wu, et al.
Neurobiology of Aging|December 3, 2014
Mitochondrial DNA haplogroup B5 confers genetic susceptibility to Alzheimer's disease in Han ChineseRui Bi, Wen Zhang, Dandan Yu, et al.
Molecular Biology Reports|November 27, 2010
Long-term intraperitoneal injection of lipopolysaccharide induces high expression of Id2 in the brain of miceLe-Yu Wang, Zeng-zhi Niu, Bian-xiang Hu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 25, 2021
Curcumin analogue C66 attenuates obesity-induced renal injury by inhibiting chronic inflammationLin Ye, Xueting Hu, Xiang Hu, et al.
Acta Pharmacologica Sinica|January 16, 2026
Discovery of a potent and orally bioavailable type Ⅰ PRMTs inhibitor for triple-negative breast cancer treatmentShu-Yan Zhou, Qiang-Sheng Zhang, Lu Li, et al.
Pageof 94